Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Existing problems in the testing for infectious diseases

K Sazama1

  • 1Department of Pathology and Laboratory Medicine, Medical College of Pennsylvania, Philadelphia 19129, USA.

Immunological Investigations
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immediate adverse reactions to platelet transfusions: whole blood derived versus apheresis platelets.

Mymensingh medical journal : MMJ·2013
Same author

The ethics of blood management.

Vox sanguinis·2007
Same author

Transfusion errors: scope of the problem, consequences, and solutions.

Current hematology reports·2003
Same author

Pretransfusion compatibility testing for red blood cell administration.

Current opinion in hematology·2001
Same author

Is undertransfusion occurring?

Transfusion·2001
Same author

Practice parameter for the recognition, management, and prevention of adverse consequences of blood transfusion. College of American Pathologists.

Archives of pathology & laboratory medicine·2000
Same journal

Riboflavin Modulates Complement Activation, Immune Cell Viability and Activation, and Neutrophil Microbicidal Functions <i>in Vitro</i>.

Immunological investigations·2026
Same journal

Pharmacological Modulation of Immunosenescence and Inflammaging: Senolytics, Senomorphics, and Emerging Therapies.

Immunological investigations·2026
Same journal

Nanoantibodies: A Review of Diagnostic and Therapeutic Applications in Respiratory Diseases.

Immunological investigations·2026
Same journal

TRIM31: A Novel Guardian Against Periodontal Inflammation via Modulation of NLRP3 Inflammasome and Macrophage Polarization.

Immunological investigations·2026
Same journal

LincRNA-Cox2 in Inflammation: Regulatory Networks, Experimental Insights, and Future Directions.

Immunological investigations·2026
Same journal

Mechanical Regulation of the Immune System: From Sensory Mechanisms to Disease Pathogenesis.

Immunological investigations·2026
See all related articles

Current blood donor screening in the USA faces challenges due to strict Food and Drug Administration (FDA) regulations, leading to testing delays and persistent risks of transfusion-transmitted infections. Improvements are needed to address detection gaps and laboratory errors.

Area of Science:

  • Medical Laboratory Science
  • Public Health
  • Regulatory Affairs

Background:

  • Current blood donor screening in the USA is subject to stringent regulation by the Food and Drug Administration (FDA).
  • FDA oversight can slow the adoption of new testing technologies and improvements.
  • Existing methods have limitations in detecting infectious agents during the window period and can produce false results.

Purpose of the Study:

  • To analyze the limitations of current infectious agent testing methods for donated blood in the USA.
  • To identify factors contributing to transfusion-related disease transmission despite regulatory controls.
  • To highlight areas for improvement in blood screening processes.

Main Methods:

  • Review of current blood screening protocols and regulatory framework in the USA.

Related Experiment Videos

  • Analysis of reported testing problems, including false positives/negatives and window period detection.
  • Examination of laboratory operational issues and their impact on test accuracy.

    • Main Results:

    • Strict FDA regulations hinder the rapid implementation of advanced blood testing methods.
    • Testing inaccuracies such as false positives and false negatives persist, even with confirmatory tests.
    • Laboratory errors, including sample handling and result reporting, contribute to transfusion risks.
    • The impact of sample variables like anticoagulants on test results is not fully understood.

    Conclusions:

    • Despite regulatory controls, current blood screening methods in the USA are insufficient to prevent all transfusion-related disease transmission.
    • Addressing methodological limitations, improving laboratory practices, and evaluating sample integrity are crucial for enhancing blood safety.
    • Continuous improvement through adherence to good manufacturing practices is essential for future advancements.